Atea Pharmaceuticals, Inc. SEC filings AVIR

Atea Pharmaceuticals, Inc. has 313 filings in SEC EDGAR's recent list, going back to Dec 11, 2013. Its latest annual report, Form 10-K, was filed on Mar 5, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 12, 2026 (results of operations). The company's fiscal year ends on December 31.

Atea Pharmaceuticals, Inc. SEC filings
Form Description Filed Period
SCHEDULE 13G Ownership over 5% (passive) Oct 6, 2026 —
10-Q Quarterly report Aug 12, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 12, 2026 Aug 12, 2026
4 Insider transaction Jun 23, 2026 Jun 18, 2026
4 Insider transaction Jun 23, 2026 Jun 18, 2026
4 Insider transaction Jun 23, 2026 Jun 18, 2026
4 Insider transaction Jun 23, 2026 Jun 18, 2026
4 Insider transaction Jun 23, 2026 Jun 18, 2026
4 Insider transaction Jun 23, 2026 Jun 18, 2026
4 Insider transaction Jun 23, 2026 Jun 18, 2026
4 Insider transaction Jun 23, 2026 Jun 18, 2026
8-K Current report
Shareholder vote results
Jun 22, 2026 Jun 18, 2026
4/A Filing May 21, 2026 May 18, 2026
4 Insider transaction May 20, 2026 May 18, 2026
10-Q Quarterly report May 12, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 12, 2026 May 12, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 6, 2026 —
DEFA14A Additional proxy material Apr 27, 2026 —
DEF 14A Proxy statement Apr 27, 2026 Jun 18, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 26, 2026 —
4 Insider transaction Mar 13, 2026 Mar 11, 2026
10-K Annual report Mar 5, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 5, 2026 Mar 5, 2026
SCHEDULE 13G Ownership over 5% (passive) Feb 9, 2026 —
4 Insider transaction Feb 3, 2026 Jan 31, 2026
4 Insider transaction Feb 3, 2026 Jan 31, 2026
4 Insider transaction Feb 3, 2026 Jan 31, 2026
4 Insider transaction Feb 3, 2026 Jan 31, 2026
4 Insider transaction Feb 3, 2026 Jan 31, 2026
4 Insider transaction Feb 3, 2026 Jan 31, 2026
8-K Current report
Results of operations
Jan 8, 2026 Jan 8, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Dec 5, 2025 —
10-Q Quarterly report Nov 12, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 12, 2025 Nov 12, 2025
S-8 Employee stock plan registration Aug 7, 2025 —
10-Q Quarterly report Aug 7, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 7, 2025 Aug 7, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 6, 2025 —
4 Insider transaction Jun 24, 2025 Jun 20, 2025
4 Insider transaction Jun 24, 2025 Jun 20, 2025
4 Insider transaction Jun 24, 2025 Jun 20, 2025
4 Insider transaction Jun 24, 2025 Jun 20, 2025
4 Insider transaction Jun 24, 2025 Jun 20, 2025
4 Insider transaction Jun 24, 2025 Jun 20, 2025
4 Insider transaction Jun 24, 2025 Jun 20, 2025
3 Initial insider ownership Jun 24, 2025 Jun 20, 2025
8-K Current report
Shareholder vote results
Jun 20, 2025 Jun 20, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 14, 2025 —
10-Q Quarterly report May 12, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 12, 2025 May 12, 2025
DEF 14A Proxy statement Apr 29, 2025 Jun 20, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 23, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Apr 17, 2025 —
8-K Current report
Material agreement, Results of operations, Officer or director change, Regulation FD disclosure
Apr 17, 2025 Apr 16, 2025
DEFA14A Additional proxy material Apr 3, 2025 —
DEFA14A Additional proxy material Apr 1, 2025 —
8-K Current report
Other events
Apr 1, 2025 Mar 31, 2025
DEFA14A Additional proxy material Mar 26, 2025 —
DFAN14A Filing Mar 26, 2025 —
DEFA14A Additional proxy material Mar 24, 2025 —
8-K Current report
Other events
Mar 24, 2025 Mar 21, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Mar 21, 2025 —
10-K Annual report Mar 6, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 6, 2025 Mar 6, 2025
SCHEDULE 13D Ownership over 5% (active) Mar 4, 2025 —
4 Insider transaction Feb 24, 2025 Feb 20, 2025
3 Initial insider ownership Feb 24, 2025 Feb 20, 2025
8-K Current report
Officer or director change
Feb 24, 2025 Feb 20, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
4 Insider transaction Feb 4, 2025 Jan 31, 2025
4 Insider transaction Feb 4, 2025 Jan 31, 2025
4 Insider transaction Feb 4, 2025 Jan 31, 2025
4 Insider transaction Feb 4, 2025 Jan 31, 2025
4 Insider transaction Feb 4, 2025 Jan 31, 2025
4 Insider transaction Feb 4, 2025 Jan 31, 2025
4/A Filing Jan 17, 2025 Jan 15, 2025
4 Insider transaction Jan 17, 2025 Jan 15, 2025
8-K Current report
Results of operations
Jan 14, 2025 Jan 13, 2025
SCHEDULE 13D Ownership over 5% (active) Dec 16, 2024 —
4 Insider transaction Dec 12, 2024 Dec 10, 2024
144 Notice of proposed sale Dec 10, 2024 —
EFFECT Filing Nov 19, 2024 —
CORRESP Letter to the SEC Nov 15, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
UPLOAD Letter from the SEC Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 12, 2024 —
S-3 Shelf registration Nov 7, 2024 —
10-Q Quarterly report Nov 7, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 7, 2024 Nov 7, 2024
4 Insider transaction Sep 19, 2024 Sep 17, 2024
144 Notice of proposed sale Sep 19, 2024 —
144 Notice of proposed sale Sep 18, 2024 —
144 Notice of proposed sale Sep 17, 2024 —
10-Q Quarterly report Aug 7, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 7, 2024 Aug 7, 2024
4 Insider transaction Jun 21, 2024 Jun 21, 2024
4 Insider transaction Jun 21, 2024 Jun 21, 2024
4 Insider transaction Jun 21, 2024 Jun 21, 2024
4 Insider transaction Jun 21, 2024 Jun 21, 2024
4 Insider transaction Jun 21, 2024 Jun 20, 2024
4 Insider transaction Jun 21, 2024 Jun 21, 2024
8-K Current report
Shareholder vote results
Jun 21, 2024 Jun 21, 2024
144 Notice of proposed sale Jun 20, 2024 —
4 Insider transaction Jun 18, 2024 Jun 16, 2024
4 Insider transaction Jun 18, 2024 Jun 16, 2024
4 Insider transaction Jun 18, 2024 Jun 16, 2024
4 Insider transaction Jun 18, 2024 Jun 16, 2024
4 Insider transaction Jun 18, 2024 Jun 16, 2024
4 Insider transaction Jun 18, 2024 Jun 16, 2024
4 Insider transaction Jun 7, 2024 Jun 5, 2024
144 Notice of proposed sale Jun 5, 2024 —
DEFA14A Additional proxy material Jun 4, 2024 —
10-Q Quarterly report May 14, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 14, 2024 May 14, 2024
DEFA14A Additional proxy material Apr 26, 2024 —
DEF 14A Proxy statement Apr 26, 2024 Jun 21, 2024
10-K Annual report Feb 28, 2024 Dec 31, 2023
8-K Current report
Results of operations
Feb 28, 2024 Feb 28, 2024
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 9, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 7, 2024 —
SC 13G Ownership over 5% (passive) Feb 7, 2024 —
4 Insider transaction Feb 2, 2024 Jan 31, 2024
4 Insider transaction Feb 2, 2024 Jan 31, 2024
4 Insider transaction Feb 2, 2024 Jan 31, 2024
4 Insider transaction Feb 2, 2024 Jan 31, 2024
4 Insider transaction Feb 2, 2024 Jan 31, 2024
4 Insider transaction Feb 2, 2024 Jan 31, 2024
144 Notice of proposed sale Feb 1, 2024 —
144 Notice of proposed sale Feb 1, 2024 —
144 Notice of proposed sale Feb 1, 2024 —
144 Notice of proposed sale Feb 1, 2024 —
144 Notice of proposed sale Feb 1, 2024 —
144 Notice of proposed sale Feb 1, 2024 —
SC 13G/A Amended ownership over 5% (passive) Jan 24, 2024 —
SC 13D/A Amended ownership over 5% (active) Nov 28, 2023 —
10-Q Quarterly report Nov 8, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 8, 2023 Nov 8, 2023
SC 13G/A Amended ownership over 5% (passive) Nov 7, 2023 —
SC 13G Ownership over 5% (passive) Oct 2, 2023 —
SC 13G/A Amended ownership over 5% (passive) Sep 11, 2023 —
10-Q Quarterly report Aug 8, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 8, 2023 Aug 8, 2023
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Jun 21, 2023 Jun 16, 2023
4 Insider transaction Jun 21, 2023 Jun 16, 2023
4 Insider transaction Jun 21, 2023 Jun 16, 2023
4 Insider transaction Jun 21, 2023 Jun 16, 2023
4 Insider transaction Jun 21, 2023 Jun 16, 2023
4 Insider transaction Jun 21, 2023 Jun 16, 2023
4 Insider transaction Jun 21, 2023 Jun 16, 2023
DEFA14A Additional proxy material Jun 12, 2023 —
DEFA14A Additional proxy material May 25, 2023 —
SC 13D Ownership over 5% (active) May 22, 2023 —
10-Q Quarterly report May 8, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 8, 2023 May 8, 2023
ARS Annual report to shareholders Apr 28, 2023 Dec 31, 2022
DEFA14A Additional proxy material Apr 28, 2023 —
DEF 14A Proxy statement Apr 28, 2023 —
10-K Annual report Feb 28, 2023 Dec 31, 2022
8-K Current report
Results of operations
Feb 28, 2023 Feb 28, 2023
SC 13G/A Amended ownership over 5% (passive) Feb 10, 2023 —
SC 13G/A Amended ownership over 5% (passive) Feb 10, 2023 —
SC 13G/A Amended ownership over 5% (passive) Feb 9, 2023 —
SC 13G/A Amended ownership over 5% (passive) Feb 9, 2023 —
4 Insider transaction Feb 2, 2023 Jan 31, 2023
4 Insider transaction Feb 2, 2023 Jan 31, 2023
4 Insider transaction Feb 2, 2023 Jan 31, 2023
4 Insider transaction Feb 2, 2023 Jan 31, 2023
4 Insider transaction Feb 2, 2023 Jan 31, 2023
4 Insider transaction Feb 2, 2023 Jan 31, 2023
SC 13G/A Amended ownership over 5% (passive) Jan 24, 2023 —
4 Insider transaction Nov 15, 2022 Nov 11, 2022
10-Q Quarterly report Nov 7, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 7, 2022 Nov 7, 2022
10-Q Quarterly report Aug 8, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 8, 2022 Aug 8, 2022
4 Insider transaction Jun 21, 2022 Jun 17, 2022
4 Insider transaction Jun 21, 2022 Jun 17, 2022
4 Insider transaction Jun 21, 2022 Jun 17, 2022
4 Insider transaction Jun 21, 2022 Jun 17, 2022
4 Insider transaction Jun 21, 2022 Jun 17, 2022
4 Insider transaction Jun 21, 2022 Jun 17, 2022
8-K Current report
Shareholder vote results
Jun 21, 2022 Jun 17, 2022
EFFECT Filing May 12, 2022 —
POS AM Filing May 10, 2022 —
10-Q Quarterly report May 10, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 10, 2022 May 10, 2022
DEFA14A Additional proxy material Apr 29, 2022 —
DEF 14A Proxy statement Apr 29, 2022 Jun 17, 2022
POS AM Filing Mar 1, 2022 —
10-K Annual report Feb 28, 2022 Dec 31, 2021
POSASR Filing Feb 28, 2022 —
8-K Current report
Results of operations
Feb 28, 2022 Feb 28, 2022
SC 13G/A Amended ownership over 5% (passive) Feb 16, 2022 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2022 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2022 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
AVIR (Nasdaq)
Fiscal year ends
December 31
Incorporated in
MA
Headquarters
Boston, MA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1593899

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.